IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2018 Holdings

Filed 2018-11-14 | 9 holdings | $163.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc.(BIIB)COM09062X103$163.2M461,85899.8%
Abbvie Inc.(ABBV)COM00287Y109$94.0K1,0000.1%
Innoviva Inc.(INVA)COM45781M101$69.1K4,535,0000.0%
Allergan PLCSHSG0177J108$65.5K344,0000.0%
Ironwood Pharmaceuticals Inc.(IRWD)COM CL A46333X108$62.2K3,367,1000.0%
Medicines Co.COM584688105$57.5K1,922,0000.0%
Intercept Pharmaceuticals Inc.(ICPTUSD)COM45845P108$32.5K257,5000.0%
Novelion Therapeutics Inc.COM NEW67001K202$3.0K1,025,0000.0%
Shire PLCSPONSORED ADR82481R106$1811,0000.0%